- Home
- EDSA vs VRME Comparison
EDSA vs VRME Comparison
Compare EDSA & VRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- VRME
- Stock Information
- Founded
- EDSA 2015
- VRME 1999
- Country
- EDSA Canada
- VRME United States
- Employees
- EDSA N/A
- VRME N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- VRME EDP Services
- Sector
- EDSA Health Care
- VRME Technology
- Exchange
- EDSA Nasdaq
- VRME Nasdaq
- Market Cap
- EDSA 13.7M
- VRME 14.5M
- IPO Year
- EDSA N/A
- VRME N/A
- Fundamental
- Price
- EDSA $4.32
- VRME $1.31
- Analyst Decision
- EDSA Strong Buy
- VRME Buy
- Analyst Count
- EDSA 2
- VRME 1
- Target Price
- EDSA $39.00
- VRME $1.50
- AVG Volume (30 Days)
- EDSA 8.4K
- VRME 14.3K
- Earning Date
- EDSA 08-09-2024
- VRME 11-06-2024
- Dividend Yield
- EDSA N/A
- VRME N/A
- EPS Growth
- EDSA N/A
- VRME N/A
- EPS
- EDSA N/A
- VRME N/A
- Revenue
- EDSA N/A
- VRME $25,428,000.00
- Revenue This Year
- EDSA N/A
- VRME $1.14
- Revenue Next Year
- EDSA N/A
- VRME $10.56
- P/E Ratio
- EDSA N/A
- VRME N/A
- Revenue Growth
- EDSA N/A
- VRME N/A
- 52 Week Low
- EDSA $2.46
- VRME $0.85
- 52 Week High
- EDSA $8.33
- VRME $2.45
- Technical
- Relative Strength Index (RSI)
- EDSA 53.46
- VRME 48.51
- Support Level
- EDSA $4.22
- VRME $1.24
- Resistance Level
- EDSA $5.00
- VRME $1.49
- Average True Range (ATR)
- EDSA 0.25
- VRME 0.11
- MACD
- EDSA 0.04
- VRME -0.00
- Stochastic Oscillator
- EDSA 53.06
- VRME 28.00
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About VRME VerifyMe Inc.
VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.